Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation.

Curr Opin Genet Dev 2007 Jun 30;17(3):182-92. Epub 2007 Apr 30.

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

The clinical implementation of array comparative genomic hybridization has revolutionized the diagnosis of patients with syndromic or nonsyndromic mental retardation. Multiple studies of hundreds of patients with idiopathic mental retardation, and normal karyotype and/or subtelomeric testing using genome-wide microarray platforms with approximately 2000 to >30,000 (tiling-path) interrogating BAC/PAC probes have detected chromosome abnormalities in up to 17% of cases. Surprisingly, some of the pathogenic changes are mosaic and not detectable in conventional karyotyping. Commercially available genome-wide microarrays with >300,000 synthesized oligonucleotide probes enable higher resolution and sensitivity and will probably replace the BAC/PAC arrays in clinical laboratories.

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0959437X0700074
Publisher Site
http://dx.doi.org/10.1016/j.gde.2007.04.009DOI Listing
June 2007
5 Reads

Publication Analysis

Top Keywords

mental retardation
12
idiopathic mental
8
>300000 synthesized
4
subtelomeric testing
4
testing genome-wide
4
genome-wide microarray
4
platforms 2000
4
microarray platforms
4
and/or subtelomeric
4
microarrays >300000
4
synthesized oligonucleotide
4
patients idiopathic
4
studies hundreds
4
multiple studies
4
enable higher
4
probes enable
4
retardation normal
4
karyotype and/or
4
oligonucleotide probes
4
normal karyotype
4

Similar Publications